Novartis Newswire
Comprehensive Real-Time News Feed for Novartis.
Results 1 - 20 of 366 in Novartis
-
4 Big Buys And 1 Big Sell By Seth Klarman
... engages in the discovery and development of drugs against viral infections. Its successful cooperation with Novartis ( NVS ) and GlaxoSmithKline ( GSK ) puts the company among the top takeover candidates. The company's involvement in the development ... Comment?
-
Abbott Labs Keeps Raising Its Dividend
... a stronger dollar and weaker stent sales. '12 guidance was cautious. It plans to cut 700 more jobs. Shares fell 1%. Novartis' (NVS) EPS climbed 8%, beating, but the Swiss giant expects ... Diversified medical giant Abbott Laboratories (ABT) reported ... Comment?
-
... in Europe for the MF indication. We are also encouraged by Incyte's collaborations with established players like Novartis ( NVS ) and Eli Lilly ( LLY ). We believe the association of big pharmaceutical companies will bolster the company with much ... Comment?
-
Seattle Genetics' Adcetris Launch: Second Survey Reveals Additional Insights
... products, including those of Optimer Pharmaceuticals ( OPTR ), Spectrum Pharmaceuticals ( SPPI ), Incyte ( INCY )/Novartis ( NVS ), Acorda Therapeutics ( ACOR ), and Auxilium Pharmaceuticals ( AUXL ). Seattle Genetics reported $10MM in Adcetris ... Comment?
-
University Teams Tap Mobile Phones and Social Networks to Fight Non-communicable Diseases
... diseases. These winning innovations and others were part of the NCD Challenge , sponsored by IBM (NYSE: IBM ) and Novartis (NYSE: NVS). The global competition was designed to bring together industry and academia to create innovative, easy-to-use ... Comment?
-
Sanofi's Balanced Model Looks Undervalued
... 2016 revenue. The most important drugs are arguably Lemtrada for multiple sclerosis (where it will compete with Novartis 's ( NVS ) Gilenya and likely Biogen Idec 's ( BIIB ) BG-12) and '353 for hyperlipidemia. Behind these are 14 other late-stage ... Comment?
-
Can The Man From Keep Novartis AG On Top?
When you ask around the drug industry who the best leader of the last two decades was, Daniel Vasella's name always comes up. He built Basel-based A Novartis from an also-ran into the most respected drug research laboratory in the pharmaceutical industry. Comment?
-
GlaxoSmithKline: A Good Mix Of Income And Opportunity
... expected it to be. What's more, the company has a deep pipeline in respiratory care and potential rivals like Novartis ( NVS ) and Forest Labs ( FRX ) have had challenges and disappointments of their own. Diabetes drug development has been much less ... Comment?
-
... who the best leader of the last two decades was, Daniel Vasella's name always comes up. He built Basel-based Novartis from an also-ran into the most respected drug research laboratory in the pharmaceutical industry. His 14 years running the company ... Comment?
-
Can The Man From Heinz Keep Novartis On Top?
w/Photo
... who the best leader of the last two decades was, Daniel Vasella's name always comes up. He built Basel-based A Novartis from an also-ran into the most respected drug research laboratory in the pharmaceutical industry. His 14 years running the ... Comment?
-
12 Dividend Companies with Large Patent Shields
... FCF Dividend Payout Ratio: 35% Most Recent Dividend Increase: 9.1% Total Debt/Equity: 0.67 Price to FCF Ratio: 10.3 Novartis ( NVS ), the large Swiss diversified health company, has a large pharmaceutical segment as well as a variety of smaller ... Comment?
-
Deal making to beat downturn is the talk of Davos
... companies are faring just as well as their U.S. peers. The largest companies in the Stoxx 600, including Shell and Novartis AG, have an average ratio of 18.2, compared with the 15.7 average of their U.S. counterparts, according to Bloomberg data. ... Comment?
-
Big Pharma's Potential Consumer Growth Avenue
... for some pharmaceutical companies is especially disconcerting. Between Pfizer's ( PFE ) birth control concerns , Novartis' ( NVS ) over the counter drug recalls and the Gilenya investigation , and a surge of good news for the smaller cap companies ... Comment?
-
Healthcare Biz Review: Novartis AG, Johnson & Johnson, Pfizer, and...
... outweigh its risks. The result contradicts earlier studies that suggested the drug may help stimulate bone growth. Novartis AG ( NYSE:NVS ), Johnson & Johnson ( NYSE:JNJ ), Pfizer Inc. ( NYSE:PFE ), and Forest Laboratories Inc. ( NYSE:FRX ) are ... Comment?
-
Biotech Buyout Portfolio: Momenta Pharmaceuticals
... a competing generic formulation of Lovenox, also known as enoxaparin. Without Watson, Momenta and partner Sandoz/Novartis ( NVS ) have the sizeable generic Lovenox market to themselves. Momenta's reformulation generated $300 million in revenues in ... Comment?
-
Novartis (NVS) Downgraded by Bank of America (BAC) to "Underperform"
Novartis was downgraded by equities research analysts at Bank of America to an "underperform" rating in a research note issued to investors on Monday. Comment?
-
How 'good' does a shampoo need to be?
... programmes as separate from core business, he said, these days CSR is at the core of everything it does. Similarly, Novartis, the pharmaceutical giant, is now devoting considerable energy to bringing health initiatives to poor people around the ... Comment?
-
The eggs could potentially contain bacteria
w/Photo
... for certain meat products. Alma Meats recalled around 320 pounds of summer sausage, ... BASEL, Switzerland (AP) - Novartis is recalling some bottles of Excedrin, NoDoz, Bufferin and Gas-X Sunday over concerns that the ... *** UPDATE 6:47 P.M. *** ... Comment?
-
Shareholder Group Slams Novartis AG Over Chairman's Pay
Shareholder group Ethos called for Novartis investors to vote against re-electing board members who were among those deciding on the pay awarded to the Swiss drugmaker's chairman, Daniel Vasella. Comment?
-
The Birth Control Pill Fiasco: Will It Be Bad For Pfizer?
... agreed to pay at least $1.2 billion to approximately 28,500 people who alleged the use of Zyprexa caused them harm. Novartis ( NVS ) In 2010, Novartis agreed to a $422.5 million settlement with the Eastern District of Pennsylvania for its off-label ... Comment?
Novartis Forum
Most Popular
- Whitney Houston dead at 48 - 258 comments
- Father Shoots Laptop Over "Disrespectful" Facebook Post - 199 comments
- Catholic Bishops Group Denounces Contraception Compromise - 203 comments
- Religion And Birth Control: Not Just a Gop Fight - 239 comments
- Argentina to state Falklands case - 321 comments
- Whitney Houston, dead at 48, a crucial member of New Jersey's music scene - 133 comments
- 1.689 WNI ditolak masuk Singapura - 75 comments
- Church's 'Gay is not okay' sign gets backlash in social media - 93 comments
- Man Attacks Pub With Chain Saw - 111 comments
- Searcy Bank VP Indicted for Possession of Child Porn Had a Connection to Kevi... - 50 comments
Copyright ©2012 Topix LLC
